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Abstract. 
 
The Eps15 homology (EH) module is a pro-
tein–protein interaction domain that establishes a net-
work of connections involved in various aspects of en-
docytosis and sorting. The finding that EH-containing 
proteins bind to Hrb (a cellular cofactor of the Rev pro-
tein) and to the related protein Hrbl raised the possi-
bility that the EH network might also influence the
so-called Rev export pathway, which mediates nucleo-
cytoplasmic transfer of proteins and RNAs. In this 
study, we demonstrate that Eps15 and Eps15R, two 
EH-containing proteins, synergize with Hrb and Hrbl 
 
to enhance the function of Rev in the export pathway. 
In addition, the EH-mediated association between 
Eps15 and Hrb is required for the synergistic effect. 
The interaction between Eps15 and Hrb occurs in the 
cytoplasm, thus pointing to an unexpected site of action 
of Hrb, and to a possible role of the Eps15–Hrb com-
plex in regulating the stability of Rev.
Key words: EH • Eps15 • Hrb • endocytosis • nucleo-
cytoplasmic transport
T
 
HE
 
 Eps15 homology (EH)
 
1
 
 domain is a protein–pro-
tein interaction module originally identified in the
tyrosine kinase substrates Eps15 (Fazioli et al.,
1993) and Eps15R (Wong et al., 1995; Coda et al., 1998).
Several EH-binding proteins have been subsequently
identified (Salcini et al., 1997). Biochemical and functional
studies implicated proteins of the EH network in endocy-
tosis and actin cytoskeleton organization (reviewed in San-
tolini et al., 1999). Other evidence points to additional
functions. In particular, the EH network might be in-
volved in the control of nucleocytoplasmic export, as sug-
gested by the finding that three EH-containing proteins,
Eps15, Eps15R, and intersectin, interact with Hrb (also
called hRip or RAB, Human Gene Nomenclature Com-
mittee approved symbols are used in this paper), a cellular
cofactor for the HIV-1 Rev protein (Bogerd et al., 1995;
Fritz et al., 1995), and with the related protein Hrbl (Sal-
cini et al., 1997; Yamabhai et al., 1998).
By shuttling between the nucleus and cytoplasm of an
infected cell, Rev induces nucleocytoplasmic export of un-
spliced and partially spliced viral mRNAs that contain a
unique Rev binding sequence (Rev response element,
[RRE]; Cullen, 1998). Rev functions through a cellular
pathway, operationally defined as the Rev export path-
way, which normally exports endogenous RNAs (Fischer
et al., 1995), and proteins that, like Rev, contain nuclear
export signals (NESs; Fridell et al., 1996; Fritz and Green,
1996; Roth et al., 1998). Efforts to identify cellular cofac-
tors mediating Rev export led to the isolation of the dis-
tantly related human Hrb (Bogerd et al., 1995; Fritz et al.,
1995) and yeast Rip1p (Stutz et al., 1995) proteins, which
were shown to enhance Rev function in cells. Both pro-
teins also are related to nucleoporins, in that they display
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 aa, amino acids; EH, Eps15 homology;
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phenylalanine-glycine (FG) repeats, a common feature of
this class of proteins. These observations led to the hy-
pothesis that Rev recruits RRE-containing RNAs to the
nuclear pore, through direct interaction with Hrb or other
nucleoporins.
Recent observations suggest a more complex picture.
The interaction between Hrb (or Rip1p) and Rev, ob-
served in the yeast two-hybrid system, could not be dem-
onstrated using purified proteins in vitro, suggesting that it
might be indirect (Stutz et al., 1996; Henderson and Perci-
palle, 1997; Neville et al., 1997). Indeed, Crm1, a shuttling
protein that belongs to the transport receptor family,
serves as a bridging factor between Hrb and Rev (re-
viewed in Ullman et al., 1997). Crm1 binds to NESs and
mediates the export of NES-containing proteins (For-
nerod et al., 1997; Stade et al., 1997). In addition, Crm1 in-
teracts with the FG repeats of Hrb and of several FG-
nucleoporins (Neville et al., 1997). Thus, Rev might be re-
cruited to nuclear pores indirectly through sequential in-
teractions with Crm1 and Hrb. There are, however, addi-
tional difficulties with this model. First, the FG-containing
region of Rip1p was shown to make only limited contribu-
tions to Rev-mediated export (Stutz et al., 1997). Second,
it is not yet certain whether Hrb is an authentic constituent
of the nuclear pore complex (Bogerd et al., 1995; Fritz et al.,
1995). Thus, while the finding that overexpression of Hrb
enhances Rev activity, albeit modestly, suggests a role for
Hrb in the Rev export pathway, the mechanisms remain to
be determined. Based on the observation of a physical in-
teraction between Eps15 (and Eps15R) with Hrb (and
Hrbl; Salcini et al., 1997), this study was undertaken to test
whether EH-mediated interactions are involved in the
control of the Rev export pathway.
 
Materials and Methods
 
Vectors
 
pDM128, pDM138, pDM121 (Huang et al., 1991), pCEVEps15, and
pCEVEps15R (Wong et al., 1995; Coda et al., 1998) have been previously
described. pMTHrb and pMTHrbl were generated by subcloning the open
reading frame of the human cDNAs into the pMT2 vector. pCEV
 
a
 
Eps15
harbors the Eps15 cDNA in the anti-sense orientation in the LTR-based
pCEV vector. pMTHA-HrbNPV was generated by changing the se-
quences coding for the four NPF motifs to sequences coding for NPV in
the pMTHA-Hrb vector (Salcini et al., 1997). pCEVEps15
 
D
 
EH, encoding
a Eps15 protein devoid of its EH domains (and encompassing amino acids
[aa] 342–897), was engineered by PCR and subcloned into pCEV. All con-
structs were sequenced in the regions that underwent genetic manipula-
tions.
 
CAT Assays
 
CV-1 cells were transfected by the calcium phosphate method, with the
CAT (chloramphenycol acetyltransferase) reporter plasmid pDM128 (100
ng) together with the Rev expression vector pDM121 (10 ng) and the
pCMV
 
b
 
gal reporter plasmid (Clontech, 100 ng). Various combinations of
pMT-Hrb (0.25 
 
m
 
g), pMT-Hrbl (0.25 
 
m
 
g), pCEVEps15 (1 
 
m
 
g), and
pCEVEps15R (1 
 
m
 
g) were also transfected. 48 h after transfection, cellu-
lar lysates were tested for 
 
b
 
-galactosidase reporter activity using a com-
mercial kit (Promega). Cellular lysates, normalized for 
 
b
 
-galactosidase ac-
tivity, were tested for CAT activity using a commercial kit (Promega).
 
Protein Studies
 
Immunoprecipitation, subcellular fractionization, and immunoblotting
were performed as previously described (Fazioli et al., 1993). Antibodies
used were: anti-Eps15 (Fazioli et al., 1993) and anti-Eps15R (Coda et al.,
1998) sera; polyclonal anti-Hrb IgGs directed against the last 19 amino ac-
ids of Hrb (Santa Cruz Biotechnology); a polyclonal anti-Hrbl serum rec-
ognizing amino acids 280–481 of the protein. Routinely, immunoblots
were stripped and reprobed with an anti-tubulin antibody, to ensure equal
protein loading in the various lanes (not shown).
 
Results
 
Eps15 and Eps15R Influence the Rev Export Pathway
 
To gain insight into the contribution of Eps15 and Eps15R
to the nucleocytoplasmic export pathway used by Rev, we
used a previously described assay based on cotransfection
of Rev with the reporter plasmid pDM128 (Huang et al.,
1991). Transcripts from this latter construct contain a CAT
coding sequence within an intron from the 
 
env
 
 region of
HIV-1, which includes an RRE. Upon cotransfection,
Rev binds to the RRE, thus allowing cytoplasmic translo-
cation and expression of the unspliced transcripts (Huang
et al., 1991). In preliminary experiments (not shown), we
transiently cotransfected CV-1 cells with pDM128 and in-
creasing amounts of a Rev expression vector pDM121.
Transactivation of CAT by Rev was linear in a range from
4–100-fold activation. For all subsequent experiments we
used an amount of pDM121 yielding 
 
z
 
20% of the maxi-
mal transactivation.
When expression vectors for Eps15 or Eps15R were
cotransfected with Rev, an increase in CAT activity,
 
z
 
50% greater than the value obtained with Rev alone,
was reproducibly detected (Fig. 1 A). Expression vectors
for Hrb, a known cofactor of Rev, and for Hrbl yielded a
comparable 50% increase in Rev activity (Fig. 1 A). All
responses were Rev dependent, since they could be abol-
ished by replacing pDM128 with pDM138, a variant con-
struct lacking the RRE sequence (Fig. 1 A), or by omitting
the pDM121 construct (not shown). The effects were also
not due to influence of Eps15, Eps15R, Hrb, or Hrbl on
transcription, since none of the corresponding vectors af-
fected expression of an exonic CAT gene under the con-
trol of an SV-40 or RSV promoter in the absence of the
RRE (not shown).
To prove the physiological relevance of Eps15 to the
Rev export pathways, we used an antisense Eps15 con-
struct (pCEV
 
a
 
Eps15). Transfection of pCEV
 
a
 
Eps15 into
CV-1 cells significantly reduced the steady state levels of
Eps15, as revealed by both immunoblotting and immuno-
fluorescence analyses (Fig. 1 B). When pCEV
 
a
 
Eps15 was
cotransfected with pDM128 and the Rev expression vec-
tor, a dose-dependent reduction in the activity of Rev was
observed (Fig. 1 C).
 
Eps15 and Eps15R Synergize with Hrb and Hrbl
 
The finding that Eps15 and Eps15R can function as cofac-
tors for the Rev export pathway prompted us to inves-
tigate whether they also synergize with Hrb and Hrbl.
We cotransfected, together with Rev and the reporter
pDM128, various combinations of the four molecules (Fig.
2). The transfected cells expressed three- to fivefold higher
levels of these proteins than mock-transfected cells (Fig. 2
A). A synergistic effect of coexpressing Eps15 or Eps15R
with either Hrb or Hrbl, was readily observable (Fig. 2 B).
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Whereas transfection of the individual plasmids (Eps15,
Eps15R, Hrb, and Hrbl) brought about an 
 
z
 
1.5-fold in-
crease in CAT activity, compared with Rev alone, various
combinations (Eps15/Hrb, Eps15/Hrbl, Eps15R/Hrb, and
Eps15R/Hrbl) caused an 
 
z
 
3.0–3.5-fold increase. Maximal
activation was thus significantly superior to the sum of the
individual effects, suggesting that Eps15 (or Eps15R) and
Hrb (or Hrbl) can synergistically activate the Rev export
pathway.
 
The EH-mediated Interaction between Eps15 and Hrb 
Is Required in the Rev Export Pathway
 
Binding of Hrb to the EH domains of Eps15 depends on
the presence of four NPF (asparagine-proline-phenylala-
nine)-containing motifs in its COOH terminus (Salcini et al.,
1997). Mutagenesis of any of the residues in the NPF con-
sensus abolishes the binding of EH domains to their tar-
gets (Salcini et al., 1997). We engineered an HA-tagged
mutant
 
 
 
of
 
 
 
Hrb (HA
 
-
 
Hrb-NPV) in which the phenylala-
nines of its four NPF motifs were substituted with valines.
The HA-Hrb-NPV mutant and a wild-type HA-tagged
Hrb (HA-Hrb) could be expressed at comparable levels
(Fig. 3 A, lanes 2 and 3). However, HA-Hrb-NPV could
no longer be coimmunoprecipitated with Eps15 (Fig. 3 A,
top, compare lane 7 with 9). HA-Hrb-NPV was also un-
able to increase CAT expression, when compared with
Rev alone, and, most importantly, was unable to synergize
with Eps15 (Fig. 3 B).
We also engineered an Eps15 mutant devoid of its EH
domains (Eps15
 
D
 
EH). We have previously shown that the
EH domains are necessary and sufficient for binding of
Eps15 to Hrb (Salcini et al., 1997). In the Rev-dependent
CAT assay, Eps15
 
D
 
EH was not able to potentiate Rev ac-
tivity, nor was it able to synergize with wild-type Hrb (Fig.
3 C). Thus the EH-mediated interaction between Eps15
and Hrb is required for their synergistic effect in the Rev
export pathway.
 
Eps15 and Hrb Might Control Rev Degradation in an 
Extranuclear Compartment
 
Hrb has been reported to have a nuclear localization, with
either nucleolar accumulation (Bogerd et al., 1995) or a
nucleoporin-like staining pattern (Fritz et al., 1995). The
existence of a cytosolic fraction has also been reported
 
Figure 1.
 
Eps15 and Eps15R influence Rev activity. (A) Rev-
dependent CAT activity in cells transfected with the indicated
vectors (underneath) and either the CAT reporter plasmid
pDM128 (filled bars) or the control pDM138 (open bars). In this
and all subsequent experiments, data are representative of at
least three independent experiments, performed on individually
transfected triplicates. (B, top) CV1 cells were transfected with
the indicated amounts of pCEV
 
a
 
Eps15. Cellular lysates (100 
 
m
 
g)
were immunoblotted with an anti-Eps15 antibody and with an
anti-tubulin antibody as a control (not shown). The levels of
Eps15 protein, determined by densitometry and adjusted to ac-
count for variations in the level of tubulin, are indicated relative
to the value in the mock-transfected lysate. (Bottom) CV1 cells
were transfected with 0.5 
 
m
 
g of pNLS-GFP (as internal refer-
ence) and 5 
 
m
 
g of pCEV
 
a
 
Eps15. Staining of cells was with rabbit
 
anti-Eps15 antibody followed by CY3-conjugated anti-rabbit IgG
and by nuclear counterstaining with DAPI. Photographs of the
same field were taken with filters specific for DAPI-, GFP-, and
Eps15(CY3)-specific fluorescences. The vast majority of cells ex-
pressing nuclear GFP, presumably expressing antisense Eps15
RNA, displayed a weaker signal for Eps15 as compared with un-
transfected cells. Cells transfected with pNLS-GFP alone or to-
gether with pCEV control vector showed normal levels of Eps15-
specific staining (not shown). (C) CV1 cells were cotransfected
with the pDM128 CAT reporter, Rev and with the indicated
amounts of either pCEV
 
a
 
Eps15 or pCEV empty vector. CAT ac-
tivities are expressed as percent inhibition in pCEV
 
a
 
Eps15 trans-
fectants, compared with mock transfectants. In all above and sub-
sequent experiments the total final amount of transfected DNA
and the individual amounts of promoter units were kept constant,
by adding appropriate amounts of control pDM, pMT, and
pCEV empty vectors.
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(Bogerd et al., 1995). Such a fraction should in principle be
the sole one available for interaction with Eps15, which is
exclusively localized to the cytoplasm (Fazioli et al., 1993).
We determined colocalization of Eps15 and Hrb by confo-
cal microscopy. An affinity purified anti-Hrb peptide se-
rum was used which recognized a single band in Western
blot (Fig. 4 A). As previously described, Eps15 showed a
punctate cytosolic distribution (Fig. 4 A). Hrb was present
both in the nucleus and in extranuclear compartments
(Fig. 4 A). The extranuclear fraction of Hrb displayed a
punctate morphology. The majority of these punctate
structures were also stained specifically by the anti-Eps15
antibody (Fig. 4 A). We do not know the nature of these
structures, which do not contain AP2, AP1 and various
markers for the ER and Golgi compartments (not show).
The nuclear fraction of Hrb was homogeneously dispersed
and did not show nucleolar accumulation or a clear nucle-
oporin-like pattern. A biochemical subcellular fractioniza-
tion confirmed the nuclear and cytosolic localization of
Hrb (Fig. 4 B). Of note, by both methods, the majority of
Hrb appeared to be present in the cytosolic compartment.
Figure 2. Eps15 and Eps15R synergize with Hrb and Hrbl. (A)
Immunoblotting analysis of Eps15, Eps15R, Hrb, and Hrbl over-
expression. Cellular proteins (100 mg) of CV-1 cells, transfected
with expression vectors for Eps15, Eps15R, Hrb, and Hrbl (1
lanes) or with the corresponding empty vector (2 lanes) were an-
alyzed by immunoblotting with antibodies specific for each pro-
tein, as indicated. The overexpressed human Eps15 migrates as a
faster band (140 kD) compared with the endogenous monkey
protein (150 kD). In repeated experiments, we observed 3–10-
fold overexpression of Eps15, Eps15R, Hrb or Hrbl when the
corresponding expression vectors were transfected either alone
of in combination. (B) Rev-dependent CAT activity in CV-1 cells
transfected with pDM128 and the indicated expression vectors.
Figure 3. Interaction between Eps15 and Hrb is required for Rev
activation. (A) C33A cells were transfected with 20 mg of
pCEVEps15 together with 20 mg of either pMTHA-Hrb (lane 2)
or pMTHA-HrbNPV (lane 3), or pMT control vector (lane 1).
Cellular lysates were immunoblotted with an anti-Eps15 serum
(top) or with an anti-HA antibody (bottom). We observed that,
due to the presence of the four amino acid substitutions, HA-
HrbNPV migrates as a faster band when compared with the cor-
responding HA-Hrb molecule. Cellular proteins from mock
(lanes 4 and 5), HA-Hrb (lanes 6 and 7) or HA-HrbNPV (lanes 8
and 9) transfectants were immunoprecipitated with either an ir-
relevant monoclonal (ns-labeled lanes 4, 6, and 8) or with the
anti-HA antibody (HA-labeled lanes 5, 7, and 9) and detected
with an anti-Eps15 (top) or with the anti-HA (bottom) antibody.
In the top panel, lane 10 corresponds to 50 mg of cellular lysate,
to serve as a reference for positioning Eps15. (B and C) Rev-
dependent CAT activity in CV-1 cells transfected with pDM128
and various mutants of Eps15 and Hrb (indicated underneath).
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The above results suggest that the action of a Eps15–
Hrb complex must somehow be exerted at the cytosolic
level. In search of a possible mechanism, we measured the
steady state levels of Rev in the presence of Eps15 alone
or in combination with Hrb/Hrbl. Transfection of Eps15 or
Hrb or Hrbl, together with Rev, caused a modest increase
in the steady state levels of Rev (Fig. 4 C). However, when
Rev was cotransfected with Eps15 with either Hrb or Hrbl,
a four- to sixfold increase in Rev levels was detected (Fig.
4 C). These differences were not due to variable transfec-
tion efficiency, since all cellular lysates displayed the same
amount of 
 
b
 
-galactosidase activity, which was expressed
by the cotransfected plasmid pCMV
 
b
 
-gal (see Materials
and Methods), and used as an internal standard.
 
Discussion
 
We have previously shown that Eps15 (and Eps15R) is as-
sociated in vivo with Hrb through its EH domain (Salcini
et al., 1997). In this study, we showed, by an antisense ap-
proach, that Eps15 is physiologically required in the Rev
export pathway. Likewise, overexpression of Eps15 (or of
Eps15R) led to a small, yet reproducible, increase in Rev
activity. The difference in the magnitude of the effects in
the two types of experiments suggests that availability of
endogenous Eps15 is not a limiting factor in the Rev ex-
port pathway. We further showed that Eps15 and Eps15R
synergize with Hrb (and Hrbl) in the control of Rev activ-
ity and that they do so through their EH-mediated physi-
cal interaction. Since Hrb has been directly implicated in
the control of the Rev export pathway, our results indicate
that an Eps15–Hrb complex is involved in this pathway.
Hrb is thought to be a recruiter of Rev to the nuclear
pore, either directly (Bogerd et al., 1995) or, more likely,
through interaction with Crm1 (Neville et al., 1997). Hrb
might, therefore, function as a nucleoporin, as also sug-
gested by the presence of FG nucleoporin-like repeats.
However, Bogerd et al. (1995) failed to detect a clear lo-
calization of Hrb in the nuclear membrane, suggesting that
Rev might sequentially interact with Hrb and then with
authentic nucleoporins. We also failed to observe a nucle-
oporin-like localization of Hrb. Our results instead point
to an unexpected site of action of Hrb, i.e., in an extranu-
clear compartment where the majority of Hrb localizes to
punctate structures where also Eps15 is present. Together
with the findings of a physical interaction between Eps15
and Hrb (Salcini et al., 1997) and of its role in Rev activa-
tion (this paper), these results indicate that an important
role of Hrb is exerted on the cytosolic side of nucleocyto-
plasmic transport.
The subcellular localization of Hrb is, therefore, critical
to the understanding of its function. Discordant findings
have been reported in literature, which, therefore, deserve
further comment. Bogerd et al. (1995) reported significant
levels of Hrb in the cytosolic fraction of HeLa cells,
whereas Fritz et al. (1995) reported exclusive partitioning
Figure 4. Eps15 and Hrb colo-
calize in the cytosol and increase
Rev levels. (A) Subcellular lo-
calization of endogenous Eps15
and Hrb proteins in CV1 cells.
Fluorescent cells were analyzed
by optical scanning of horizontal
sections using confocal micros-
copy. A representative horizon-
tal section is shown (green, Hrb;
red, Eps15; yellow, merged).
The specificity of the anti-Hrb
antibody was confirmed by immunoblot (right-most panel) on 100 mg of total proteins from CV-1 cells. Lane 1, staining with normal
goat serum; lane 2, staining with anti-Hrb, lane 3, staining with anti-Hrb preincubated with the cognate peptide. Preincubation of the
anti-Hrb antibody with the specific peptide also resulted in no signal in immunofluorescence analysis (not shown). (B) Subcellular frac-
tionization. Subcellular fractions of CV-1 cells are identified as C (cytosolic), N (nuclear) and M (membrane), or T (total lysate). Ali-
quots of each fraction, representative of the same number of cells (1 3 106), were analyzed by immunoblot for the presence of EGFR
(membrane marker), PLC-g (cytosolic marker), hRNPL (nuclear marker) and Hrb. As evident C and M fraction are .95% pure,
whereas the nuclear fraction was z10% contaminated by membranes. (C) Steady state levels of the Rev protein in various transfec-
tants. Immunoblot analysis with the antibodies indicated on the right was performed on CV-1 cells (2.5 3 105) transfected with various
combinations of plasmids. Transfectants were: 1, mock; 2, Rev; 3, Rev and Eps15; 4, Rev and Hrb; 5, Rev and Hrbl; 6, Rev, Eps15, and
Hrb; 7, Rev, Eps15, and Hrbl.
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in the nuclear fraction in the same cells. Our results agree
with those of Bogerd et al., except that the magnitude of
the cytosolic pool appears relatively greater under our
conditions of analysis. Our morphological analysis, how-
ever, diverges from previous literature in which Hrb was
found predominantly in the nucleus by immunofluores-
cence (Bogerd et al., 1995; Fritz et al., 1995). We note that
in previous studies polyclonal anti-Hrb antibodies were
used that were generated against portions of Hrb contain-
ing multiple FG repeats and displaying homology to other
nucleoporins. One might speculate that those sera were
cross-reactive with authentic nucleoporins. In our case, we
used an anti-peptide serum, which was generated against a
portion of Hrb without significant homologies.
The mechanisms by which a cytosolic Eps15–Hrb com-
plex participates to the regulation of the Rev export path-
way remain to be elucidated. A direct effect on the rate of
nucleocytoplasmic export of Rev might result in altered
partitioning of Rev. However, attempts to verify whether
overexpression of Eps15 and Hrb could alter the nuclear vs.
cytosolic partitioning of Rev did not reveal any significant
effect (not shown). However, we noticed, increased levels
of immunoreactive Rev (not shown). This prompted us to
perform a quantitative biochemical analysis of the steady
state levels of Rev under conditions of overexpression of
Eps15 and Hrb. Our finding of a significant increase in
Rev levels upon concomitant overexpression of the two
proteins provides a mechanistic basis for their synergistic
effect on Rev activity.
Increased Rev levels might reflect stabilization of the
protein, or of its mRNA, or an increased transcription/
translation rate. The possibility that Eps15–Hrb affects
Rev stability is an intriguing one. Rev is less stable in the
cytosol than in the nucleus (Kubota et al., 1996), thus pre-
dicting the existence in the cytosol of a molecular machin-
ery able to divert it from its metabolic destiny, to allow re-
import into the nucleus. The Eps15–Hrb complex might be
part of this machinery. The Rev export pathway has re-
cently come into focus as a major mechanism involved in
the regulation of levels of important proteins such as
hdm2, p53, and NUMB, by targeting them to cellular com-
partments (nucleus or cytosol) appropriate for their degra-
dation by the 26S proteasome (Juven-Gershon et al., 1998;
Roth et al., 1998). It is thus possible that the Eps15–Hrb
complex is involved in the regulation of the trafficking of
cellular proteins whose localization and stability are con-
trolled through the Rev export pathway.
The EH network is implicated in the control of endocy-
tosis and actin cytoskeleton organization (reviewed in
Santolini et al., 1999). Our results indicate additional lev-
els of involvement, i.e., modulation of nucleocytoplasmic
shuttling and possibly of protein degradation. We note
that both Eps15 and Eps15R possess FG repeats in their
COOH termini. In addition, another component of the
clathrin coat, AP-180 also displays FG repeats. It will be of
interest, therefore, to analyze whether endocytic proteins
interact with members of the importin family. If true, this
would unveil an unexpected convergence of molecular
machineries governing vesicle sorting and nucleocytoplas-
mic shuttling.
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